- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVAX
Recent news which mentions NVAX
From Benzinga
Why Pfizer and BioNTech Stocks Zoomed Higher Today
September 29, 2023
From Motley Fool
NVAX, AI, CVNA: The 3 Most Shorted Stocks This Month
September 28, 2023
From InvestorPlace
Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done
September 26, 2023
From InvestorPlace
Does This Message From Moderna Mean Bad News for Novavax?
September 21, 2023
From Motley Fool
You Can Pick Up These High-Risk, High-Reward Stocks for Less Than $10
September 19, 2023
From Motley Fool
From Benzinga
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
September 15, 2023
From Benzinga
Why COVID Vaccine Demand Might Not Be That Strong
September 14, 2023
From Motley Fool
Novavax Is a Step Behind, Again. Should You Be Worried?
September 14, 2023
Tickers
NVAX
From Motley Fool
From Benzinga
Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Tending Today
September 11, 2023
From Benzinga
Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits
September 11, 2023
From Benzinga
New Pfizer and Moderna COVID shots approved by FDA
September 11, 2023
From MarketWatch
7 Biotech Stocks to Sell in September Before They Crash & Burn
September 06, 2023
From InvestorPlace
From Benzinga
This Down-on-Its-Luck Biotech Could Surge 150%, Wall Street Says. Should You Buy the Stock?
September 06, 2023
Tickers
NVAX
From Motley Fool
Novavax, Zscaler, Digital Brands Group, Asana, Tesla: Why These 5 Stocks Are Drawing Investor Attention Today
September 05, 2023
From Benzinga
Coronavirus Cases Are on the Rise -- Should You Buy Vaccine Stocks?
September 05, 2023
From Motley Fool
7 Undervalued Stocks Due for a Massive Short Squeeze
September 01, 2023
From InvestorPlace
3 Biotech Stocks Due for a Massive Short Squeeze
August 31, 2023
From InvestorPlace
Tickers
NVAX
From Motley Fool
From InvestorPlace
Why Novavax Stock Was So Healthy on Monday
August 28, 2023
From Motley Fool
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 28, 2023
From Benzinga
COVID is evolving quickly in white-tailed deer, study finds
August 28, 2023
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.